DexCom Inc
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3033% below fair value
$79.32−0.87 (-1.08%)
Close on Nov 20, 2026Market cap $29.58BP/E 31.2Yield –
DexCom Goodwill: $24M in Q3 2026, down 0.4% from a year earlier.
Latest, Q3 2026
24
Period ended Sep 30, 2026
Change on a year earlier
-0.4%
24.1 in Q3 2025
History
60 quarters
Since Q4 2011
Sources
59
Documents cited below
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-10-29) ↗
Reported in Form 10-K & Form 10-Q Balance Sheets.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). DexCom Goodwill ($M), quarterly Q4 2011–Q3 2026 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/ctx-goodwill
See every metric in the DexCom KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?